Race Oncology Plans Investor Engagement Drive in June with ASX300 Spotlight

2 min read | June 02, 2025 04:30 PM AEST | By Team Kalkine Media

Google News:

Race Oncology Plans Investor Engagement Drive in June with ASX300 Spotlight — Image source: Shutterstock

Recent News

Zip Shares Push Higher as Market Watches Key Turning Point

Could These Under-the-Radar ASX Stocks Be Worth Watching?

ASX 200 Soars as Trump Signals Surprise Iran Peace Shift

Which ASX Small Caps Are Making Early Moves Today?

Make Kalkine Media
My Trusted Source

Highlights

Race Oncology (RAC) to present at June investor events

Key updates on lead asset bisantrene (RC220) to be shared

Brisbane investor briefing scheduled for June 27

Race Oncology (ASX:RAC), a clinical-stage biotechnology company focused on precision oncology, is gearing up for a dynamic end to June with two key investor engagement events. The company is set to participate in the Gold Coast Investment Showcase on June 25–26, 2025, followed by an in-person investor briefing in Brisbane on June 27. These events come as Race Oncology continues advancing its flagship clinical asset, bisantrene (RC220), a next-generation formulation targeting cancer therapy, and explores new partnership opportunities.

The Gold Coast Investment Showcase, hosted at the JW Marriott Gold Coast Resort & Spa, provides a platform for ASX-listed companies to connect with investors from across Australia. Dr Daniel Tillett, Chief Executive Officer of Race Oncology, will present at 10:30 am on Thursday, June 26. Throughout the event, both Tillett and the Race team will be available at the company’s booth to offer insights into the latest progress in their clinical programs and ongoing development of RC220.

Race’s presence at the Showcase reflects a broader push to communicate its strategic objectives and build relationships with shareholders, prospective investors, and the broader market. With the company also being part of the ASX300, Race continues to draw interest from those following emerging opportunities within Australia's most tracked equities.

In addition to the Showcase, Race will host a Brisbane investor briefing on Friday, June 27. This in-person session will be held at Workspace 365, Level 4, 260 Queen Street, Brisbane, beginning at 10:30 am. Both Tillett and Executive Chairman Dr Pete Smith will lead the presentation, covering recent advancements, company outlook, and key milestones ahead. Attendees will also have the opportunity to ask questions and engage directly with Race’s leadership team in a relaxed setting, accompanied by a light morning tea.

The investor outreach comes as Race Oncology strengthens its clinical roadmap and explores avenues to expand patient access through collaborative efforts. Events like these provide shareholders with meaningful insights and allow the company to showcase its evolving position in the biotech sector.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.